Advances in Speech Tech for Dysarthria Patientsby Lilu Anderson 29.09.2024New study improves voice recognition for dysarthria, aiding Parkinson's patients with communication.
Novartis Partners with Generate in $1B Biotech Dealby Lilu Anderson 26.09.2024Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
Ahammune Biosciences Secures $5M for Vitiligo Trialsby Lilu Anderson 25.09.2024Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
Top Funding Rounds: Biotech and AI Lead with Big Winsby Lilu Anderson 14.09.2024Biotech and AI sectors see major funding, with Candid Therapeutics' $370M and Glean's $260M rounds leading the way this week.
Moderna Cuts R&D by $1.1B, Focus on Key Approvalsby Mark Eisenberg 12.09.2024Moderna shares dip as R&D spending reduces, focusing on FDA approval for 10 key products including RSV and cancer treatments.
Vir Biotechnology Names Jason O’Byrne CFOby Lilu Anderson 10.09.2024Vir Biotechnology appoints Jason O’Byrne as CFO, effective October 2, 2024, boosting financial strategy and leadership.
AI’s Impact on Modern Tech: A Detailed Insightby Lilu Anderson 07.09.2024Explore AI's role in transforming healthcare, finance, transportation, and daily life with key benefits and challenges.
Medera’s SPAC Merger Marks Rare Biotech Moveby Lilu Anderson 06.09.2024Medera aims for Nasdaq listing via SPAC to boost gene therapies, spotlighting rare biotech SPACs in 2024.
Boehringer Ingelheim’s Strategic Move in Pet Healthby Lilu Anderson 03.09.2024Boehringer Ingelheim acquires Saiba Animal Health, boosting pet R&D with innovative therapeutic vaccines.
SparkLabs Launches $50M AIM AI Fund Globallyby Lilu Anderson 03.09.2024SparkLabs announces $50M AIM AI Fund to support AI startups, expanding opportunities beyond Silicon Valley.